-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Cavernous malformations (CMs) are dilated blood vessels with a typical mulberry-like appearance that occur in veno-capillaries without interfering with brain parenchyma, muscle, or elastic tissue
.
According to the latest International Society for the Study of Hemangioma (ISSVA) classification of vascular abnormalities, CMs are defined as slow-flow venous malformations
The meta-analysis was performed to unify the results of all possible treatment regimens, clarify their efficacy, and specify factors associated with the dynamic behavior of CCMs
PubMed, Cochrane Library, Science Direct, ISI Web of Science, Embase and other sources were searched to identify cohort studies published between 1990 and 2020 on the treatment of CCMs
.
Preferred reporting item following guidelines for systematic reviews and meta-analyses; the Newcastle-Ottawa scale was used to assess risk of bias and limitations were assessed based on selection/outcome bias
Assess risk factors for poor treatment outcomes
Efficacy and mortality/mortality for each treatment
During the follow-up of 41,098 people, a total of 100 cohorts were analyzed, of which 8,994 patients were treated with CCMs
.
Effectiveness in ensuring bleeding prevention was 97% in surgery, 86% in radiosurgery, and 77% in conservative management
During the follow-up of 41,098 people, a total of 100 cohorts were analyzed, of which 8,994 patients were treated with CCMs
Post-treatment bleeding rates in radiosurgery, association with patients, and study characteristics
Surgery is usually considered first-line treatment
.
Surgical intervention may be considered in patients with a history of two or more hemorrhages, neurological deficits, or uncontrolled epilepsy, based on long-term accepted thresholds
Surgery is usually considered first-line treatment
BubenikovaA ,SkalickyP ,Benes JrV , et al Overview of cerebral cavernous malformations: comparison of treatment approaches Journal of Neurology, Neurosurgery & PsychiatryPublished Online First:10 March 2022.
BubenikovaA ,SkalickyP ,Benes Jr V Bubenikova ABubenikova Skalicky PSkalicky Benes Jr VBenes Jr, et al Overview of cerebral cavernous malformations: comparison of treatment approaches Overview of cerebral cavernous malformations: comparison of treatment approachesJournal of Neurology, Neurosurgery & Psychiatry Published Online First: 10 March 2022.
leave a message here
